M Z1
Pill imprint M Z1 has been identified as Zolpidem tartrate 5 mg.
Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy.
Zolpidem 5 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Zolpidem tartrate Images
- Imprint:
-
M Z1
- Strength:
- 5 mg
- Color:
- Purple
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
crospovidone
D&C Red No. 30
calcium phosphate dibasic anhydrous
FD&C Blue No. 2
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5305
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0724 | UDL Laboratories Inc |
| 54868-0845 | Physicians Total Care Inc (repackager) |
| 55887-0124 | Diversified Healthcare Services Inc (repackager) |
| 67544-1027 | Prepak Systems Inc (repackager) |
| 18837-0256 | Innoviant Pharmacy Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Zolpidem Tartrate resources
- Zolpidem
- Zolpidem (Wolters Kluwer)
- Zolpidem Extended-Release Tablets (Wolters Kluwer)
- Zolpidem Oral Spray (Wolters Kluwer)
- zolpidem (Cerner Multum)
- zolpidem Oral, Oromucosal (Micromedex) - Includes Dosage Information
- Zolpidem Tartrate (AHFS DI)
- Zolpidem (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Tartrate (Wolters Kluwer)
Search Again
